Time and attention + active fructooligosaccharide supplementation (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 96 | Crohn disease | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00343642 (ClinicalTrials.gov) | September 2006 | 21/6/2006 | Dietary Treatment of Crohn's Disease | Dietary Treatment of Crohn's Disease | Crohn's Disease;Inflammatory Bowel Disease | Dietary Supplement: Time and attention + fructo-oligosaccharide placebo;Dietary Supplement: dietary therapy + fructo-oligosaccharide placebo;Drug: Time and attention + active fructooligosaccharide supplementation | Rush University Medical Center | National Center for Complementary and Integrative Health (NCCIH) | Completed | 18 Years | 80 Years | Both | 73 | Phase 1;Phase 2 | United States |